WINDTREE THERAPEUTICS INC (WINT) Stock Fundamental Analysis

NASDAQ:WINT • US97382D6004

0.11 USD
-0.37 (-77.21%)
At close: Aug 20, 2025
0.1048 USD
-0.01 (-4.73%)
After Hours: 8/20/2025, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Overall WINT gets a fundamental rating of 1 out of 10. We evaluated WINT against 520 industry peers in the Biotechnology industry. WINT has a bad profitability rating. Also its financial health evaluation is rather negative. WINT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year WINT has reported negative net income.
  • In the past year WINT has reported a negative cash flow from operations.
  • WINT had negative earnings in each of the past 5 years.
  • In the past 5 years WINT always reported negative operating cash flow.
WINT Yearly Net Income VS EBIT VS OCF VS FCFWINT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • WINT has a worse Return On Assets (-77.52%) than 65.81% of its industry peers.
  • With a Return On Equity value of -183.17%, WINT is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -77.52%
ROE -183.17%
ROIC N/A
ROA(3y)-85.45%
ROA(5y)-61.66%
ROE(3y)-383.83%
ROE(5y)-246.99%
ROIC(3y)N/A
ROIC(5y)N/A
WINT Yearly ROA, ROE, ROICWINT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

  • WINT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WINT Yearly Profit, Operating, Gross MarginsWINT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K -10K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, WINT has more shares outstanding
  • WINT has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for WINT has been reduced compared to a year ago.
WINT Yearly Shares OutstandingWINT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K 200K 250K
WINT Yearly Total Debt VS Total AssetsWINT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • WINT has an Altman-Z score of -47.63. This is a bad value and indicates that WINT is not financially healthy and even has some risk of bankruptcy.
  • WINT has a Altman-Z score of -47.63. This is amonst the worse of the industry: WINT underperforms 92.65% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that WINT is not too dependend on debt financing.
  • The Debt to Equity ratio of WINT (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -47.63
ROIC/WACCN/A
WACCN/A
WINT Yearly LT Debt VS Equity VS FCFWINT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • WINT has a Current Ratio of 0.25. This is a bad value and indicates that WINT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.25, WINT is doing worse than 94.85% of the companies in the same industry.
  • A Quick Ratio of 0.25 indicates that WINT may have some problems paying its short term obligations.
  • The Quick ratio of WINT (0.25) is worse than 94.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25
WINT Yearly Current Assets VS Current LiabilitesWINT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • WINT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -236.14%.
EPS 1Y (TTM)-236.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 14.49% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y84.67%
EPS Next 2Y41.23%
EPS Next 3Y25.96%
EPS Next 5Y14.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
WINT Yearly Revenue VS EstimatesWINT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2022 2030 2031 50M 100M 150M 200M
WINT Yearly EPS VS EstimatesWINT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -200K -400K -600K -800K

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WINT. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WINT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WINT Price Earnings VS Forward Price EarningsWINT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WINT Per share dataWINT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300

4.3 Compensation for Growth

  • A more expensive valuation may be justified as WINT's earnings are expected to grow with 25.96% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.23%
EPS Next 3Y25.96%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for WINT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

WINDTREE THERAPEUTICS INC

NASDAQ:WINT (8/20/2025, 8:00:02 PM)

After market: 0.1048 -0.01 (-4.73%)

0.11

-0.37 (-77.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-18
Earnings (Next)11-24
Inst Owners1.23%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner Change0%
Market Cap3.23M
Revenue(TTM)N/A
Net Income(TTM)-20.75M
Analysts43.33
Price Target180.54 (164027.27%)
Short Float %0.05%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.21
Dividend Growth(5Y)N/A
DP-3.6%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-400
EYN/A
EPS(NY)-2.2
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0
BVpS0.39
TBVpS-0.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -77.52%
ROE -183.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-85.45%
ROA(5y)-61.66%
ROE(3y)-383.83%
ROE(5y)-246.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z -47.63
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)55.35%
Cap/Depr(5y)88.07%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-236.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.42%
EPS Next Y84.67%
EPS Next 2Y41.23%
EPS Next 3Y25.96%
EPS Next 5Y14.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y38.92%
OCF growth 3YN/A
OCF growth 5YN/A

WINDTREE THERAPEUTICS INC / WINT FAQ

Can you provide the ChartMill fundamental rating for WINDTREE THERAPEUTICS INC?

ChartMill assigns a fundamental rating of 1 / 10 to WINT.


What is the valuation status for WINT stock?

ChartMill assigns a valuation rating of 1 / 10 to WINDTREE THERAPEUTICS INC (WINT). This can be considered as Overvalued.


What is the profitability of WINT stock?

WINDTREE THERAPEUTICS INC (WINT) has a profitability rating of 0 / 10.


Can you provide the dividend sustainability for WINT stock?

The dividend rating of WINDTREE THERAPEUTICS INC (WINT) is 0 / 10 and the dividend payout ratio is -3.6%.